Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T16:12:57.780Z.
Calculation as of: 2026-10-06T16:12:57.780Z.
Quote observation: 2026-10-06T16:09:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4f151a916dea3ce6c644edeede267ba6baff28ecbaa47bdba7dbcda8d51ae25
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$5.33B
PS Ratio
0.72
TTM Avg
0.65
3Y Avg
0.77
5Y Avg
0.75
Market Cap
$5.16B
PS Ratio
5.43
TTM Avg
5.29
3Y Avg
3.99
5Y Avg
3.36
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maase Inc. (MAAS) | $5.25B | N/A | N/A | N/A | N/A |
| ACI Worldwide, Inc. (ACIW)vs › | $5.18B | 2.85 | 2.75 | 2.86 | 2.60 |
| Science Applications International Corporation (SAIC)vs › | $5.33B | 0.72 | 0.65 | 0.77 | 0.75 |
| Kulicke and Soffa Industries, Inc. (KLIC)vs › | $5.16B | 5.43 | 5.29 | 3.99 | 3.36 |
| Octave Intelligence plc (OCTV)vs › | $5.36B | N/A | N/A | N/A | N/A |
| Navan, Inc. (NAVN)vs › | $5.14B | 6.23 | 4.49 | 4.49 | 4.49 |
| Core Scientific, Inc. (CORZ)vs › | $5.40B | 12.27 | 17.61 | 10.80 | 10.80 |
| Novanta Inc. (NOVT)vs › | $5.42B | 5.26 | 5.30 | 5.73 | 6.20 |
| Klaviyo, Inc. (KVYO)vs › | $5.05B | 3.64 | 5.13 | 8.34 | 8.44 |
| ExlService Holdings, Inc. (EXLS)vs › | $5.45B | 2.44 | 2.62 | 3.27 | 3.58 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute